Browse studies

Find your next paid study

3,226 recruiting studies matching your filters

Phase 1 Study of Trastuzumab Deruxtecan (DS-8201a) in Combination With Azenosertib (ZN-c3) in HER2-Expressing/Amplified Gastric/Gastroesophageal Junction Cancer and Other Solid Tumors

This phase I trial tests the safety, side effects, and best dose of azenosertib in combination with trastuzumab deruxtecan in treating patients with HER2-posit…

Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+10 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06364410

Phase 2

A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)

Phase 2 Study of TYRA-300 in FGFR3 Altered Low Grade, Intermediate Risk NMIBC

Low-grade NMIBCFGFR Gene AmplificationFGFR Gene Alterations+3 more

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Tyra Biosciences, IncNCT06995677

Phase 1

A Phase 1 Window-of-Opportunity Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

SRN-101 is designed to destroys tumor cells while simultaneously activating the immune system to fight cancer. This is a first in human, single arm study to ev…

Recurrent High-Grade GliomasBrain NeoplasmGlioma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Nicholas ButowskiNCT07826949

Phase 1: Thrive Together: A Feasibility and Acceptability Evaluation of Peer Mentoring for High Schoolers With ADHD and Their Caregivers

During this first phase of the study, the investigators are conducting focus group to conduct a needs assessment. Specifically, the investigators will be holdi…

Attention-Deficit/Hyperactivity Disorder (ADHD)

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT07894094

Phase 2

Phase II Study of Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant in T-Cell Lymphoma

This phase II trial tests how well ruxolitinib as a maintenance medication works to prevent relapse and graft-versus-host disease (GVHD) for patients who have …

T-cell LymphomaGraft Versus Host DiseaseLymphoma, T-Cell+5 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT07356245

Phase 2

A Randomized Phase 2 Study to Evaluate the Efficacy and Safety for Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer (Cornerstone-004)

The purpose of this phase 2 study is to assess the efficacy and safety for adjuvant therapeutic cancer vaccine AST-201 (pUMVC3-hIGFBP-2) in patients with newly…

Advanced Ovarian Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Aston Sci. Inc.NCT05794659

Phase 1

Phase 1 Study of TMV Vaccine Alone or TMV Vaccine Plus Toripalimab-tpzi in Loco-Regionally Recurrent Head and Neck Squamous Cell Carcinoma

The goal of this clinical trial is to learn if an experimental, personalized cancer vaccine called TMV vaccine is safe and to find the best dose to study in fu…

Squamous Cell Carcinoma of Head and NeckSquamous Cell Carcinoma of Head and Neck (SCCHN)HNSCC+2 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Metaclipse Therapeutics CorporationNCT07898124

Observational

Combating Alzheimer's Through Sleep and Exercise (CASE)

The Combating Alzheimer's through Sleep and Exercise (CASE) study is an exploratory, hypothesis-generating trial designed to: (1) assess whether improvements i…

DementiaMild Cognitive Impairment (MCI)Cognitively Unimpaired+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT04855630

Phase 1

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

A Phase 1/1B Study of ST-01156 in Patients with Advanced Solid Malignancies

Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

SEED Therapeutics, Inc.NCT07197554

Phase 3

Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that …

Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+2 more

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Cancer Institute (NCI)

Phase 3

Radiotherapy With Concurrent Cetuximab vs. Carboplatin and Paclitaxel in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin: A Pragmatic Phase III Randomized Trial (CONCISE)

This phase III trial compares cetuximab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients w…

Locally Advanced Hypopharyngeal Squamous Cell CarcinomaLocally Advanced Laryngeal Squamous Cell CarcinomaLocally Advanced Oral Cavity Squamous Cell Carcinoma+1 more

Estimated

~$50 – $2,250

Actual pay is set by the research site.

NRG OncologyNCT07441681

Observational

Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Brown Rice

The purpose of this research study is to identify biomarkers (measurable signs). in the body like substances in blood or urine) of whole-grain (WG) brown rice…

Healthy Adult MalesHealthy Adult Females

Estimated

~$10 – $750

Actual pay is set by the research site.

North Carolina Agriculture & Technical State UniversityNCT07898137